Local Anesthesia Drugs Market Size, Share & Trends Analysis Report By Product (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine), By Application, And Segment Forecasts, 2018 - 2025

Industry Insights

The local anesthesia drugs market size was valued at USD 4.65 billion in 2016 and is expected to expand at a CAGR of 3.7% over the forecast period. There has been an increase in number of surgical procedures performed across the globe, including dental procedures, cosmetic surgeries, and plastic surgeries. This is a major factor driving the market for local anesthetics.

A key trend observed in the market is a significant rise in demand for post-operative pain relief options, on the heels of increasing number of surgical procedures. This trend is likely to continue throughout the forecast period, positively influencing the demand for local anesthesia drugs. An approximate 65.0% of the total surgical procedures performed need post-operative pain management.

Growth in number of surgeries performed can be attributed to aging population, a demographic group that is more prone to chronic diseases such as cardiovascular disorders, respiratory ailments, cancer, neurological disorders, and other gastro, orthopedic, and spinal problems. Advancements in drug delivery technologies is also expected to contribute to demand for local anesthetics in surgical procedures. For instance, DepoFoam technology uses a new method to deliver bupivacaine and is very efficient in management of post-operative pain.

The growth of the market for local anesthesia drugs is also fueled by introduction of new and effective drugs such as articaine, levobupivacaine, and ropivacaine. This growth is supplemented by increasing healthcare expenditure in developing countries such as India, China, and Brazil, where the number of surgeries performed has been on a steady rise.

Product Insights

On the basis of product, the local anesthesia drugs market has been segmented into bupivacaine, ropivacaine, lidocaine, chloroprocaine, prilocaine, benzocaine, and other local anesthetics. The lidocaine drug dominated the market in 2016 owing to its extensive use as a topical and injectable anesthetic. Entry of newer drugs such as articaine and bupivacaine will, however, threaten to challenge the market share of this drug over the forecast period.

Bupivacaine is expected to witness the fastest growth through 2025 due to significant number of clinical trials conducted on the drug as of 2016. The growth is also attributed to its extensive use in post-operative pain management. Drugs such as ropivacaine and articaine are also expected to witness promising growth over the forecast period.

Application Insights

In terms of application, the market for local anesthesia drugs has been bifurcated into injectable and surface anesthetics. By way of revenue, the injectable anesthetics segment dominated the market and this trend is likely to continue during the forecast period. This is primarily attributed to extensive usage of injectable anesthetics in different surgical procedures. Surface anesthetics, on the other hand, are anticipated to witness the fastest growth over the forecast period. Advancements in drug delivery systems are expected to be the key driving factor for this segment.

Regional Insights

North America held the largest share in the market owing to significant number of surgical procedures performed in U.S. The country accounts for more than 25.0% of surgical procedures performed across the globe. High per capita income, improved access to healthcare, increase in prevalence of chronic diseases, and rising geriatric population are driving the market for local anesthesia drugs in this region.

Europe held the second largest share as of 2016 and is expected to witness decent growth during the forecast period. The growth is attributed to increasing volume of dental and cosmetic surgeries, advancements in surgical procedures, and growing use of local anesthetics in post-operative pain management.

The Asia Pacific and Latin American markets are expected to exhibit lucrative growth over the forecast period owing to expanding geriatric population, which is anticipated to drive the number of surgical procedures performed in the region. Decline in opioid use in the region is also expected to contribute to market growth.

Local Anesthesia Drugs Market Share Insights

Some of the key players in the market for local anesthesia drugs are Aspen Pharmacare; Fresenius Kabi; Novartis, Inc.; Sagent Pharmaceutical; Pacira Pharmaceutical; Mylan; and Teva Pharmaceuticals. There are numerous regional and local generic players in the market, which makes the market increasingly competitive. GlaxoSmithKline and AstraZeneca recently divested their anesthesia portfolio to Aspen Pharmacare, making Aspen one of the largest suppliers of anesthesia drugs across the globe.

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research, Inc. has segmented the local anesthesia drugs market report on the basis of product, application, and region:

• Product Outlook (Revenue, USD Million, 2014 - 2025)

  • Bupivacaine

  • Ropivacaine

  • Lidocaine

  • Chloroprocaine

  • Prilocaine

  • Benzocaine

  • Other local anesthetics

• Application Outlook (Revenue, USD Million, 2014 - 2025)

  • Injectable

  • Surface Anesthetic

• Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

  • Asia Pacific

    • China

    • Japan

  • Latin America

    • Brazil

    • Mexico

  • MEA

    • South Africa